Table of contents

  1. Front Matter
    Pages i-xii
  2. J. A. Gray, S. A. Whatley, M. Snape
    Pages 13-38
  3. D. G. Grahame-Smith
    Pages 46-55
  4. M. Briley, P. Chopin, C. Moret
    Pages 56-73
  5. J. F. W. Deakin, F. S. Guimarães, M. Wang, J. Hellewell, R. Hensman
    Pages 74-93
  6. J. De Vry, T. Glaser, T. Schuurman, R. Schreiber, J. Traber
    Pages 94-129
  7. L. E. Schechter, F. J. Bolaños, H. Gozlan, A.-M. Laporte, C.-M. Fattaccini, M. Hamon
    Pages 145-153
  8. G. Curzon, E. L. Gibson, A. J. Kennedy, G. A. Kennett, G. S. Sarna, P. Whitton
    Pages 154-167
  9. F. S. Abuzzahab
    Pages 185-189
  10. P. Abadie, J. C. Bisserbe, J. P. Boulenger, J. M. Travere, L. Barre, M. C. Petit et al.
    Pages 203-210
  11. S. E. File, P. K. Hitchcott
    Pages 237-255
  12. A. L. Johnston
    Pages 347-365
  13. D. N. Stephens, J. S. Andrews, L. Turski, H. H. Schneider
    Pages 366-381
  14. R. Trullas, J. T. Winslow, T. R. Insel, P. Skolnick
    Pages 382-394
  15. H. V. Curran
    Pages 395-405
  16. R. G. Lister
    Pages 406-417
  17. J.-P. Boulenger, J.-C. Bisserbe
    Pages 458-468
  18. M. Ansseau, R. von Frenckell
    Pages 469-480
  19. Back Matter
    Pages 481-491

About this book


This book brings together invited contributions on the current thinking on anxiety, from fundamental research to the development of new anxiolytics. It will be of interest and use to all neuropharmacologists and psychiatrists researching into anxiety.


depression kinin neuropharmacology neurotransmitter pathophysiology pharmacology physiology research Serotonin

Editors and affiliations

  • M. Briley
    • 1
  • S. E. File
    • 2
  1. 1.Pierre Fabre MédicamentFrance
  2. 2.Psychopharmacology Research UnitUMDS, Guy’s HospitalLondonUK

Bibliographic information